Longitudinal Study Design
Cross-source consensus on Longitudinal Study Design from 1 sources and 4 claims.
1 sources · 4 claims
Other
Highlighted claims
- The protocol describes a multicentre observational longitudinal case-comparison study at three US sites. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- Participants are followed for two years after enrolment and classified using objective pulmonary endpoints. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- The discovery cohort will enrol 220 sarcoidosis cases with a target of 100 progressive and 100 non-progressive cases for classifier development. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- Recruitment began in November 2023 and two-year follow-up is planned to complete in August 2028. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression